Josh Marshall tells us that he has wonderful news.
Today I’m really excited to announce that we’ve launched a very cool new section to our popular Idea Lab vertical called Idea Lab: Impact, which is being sponsored by the Pharmaceutical Research and Manufacturers of America. I’ve wanted to take Idea Lab in this direction for some time. Ideal Lab focuses science, cutting edge technology, the tech industry and the economics, policy and politics that surrounds those issues and sometimes on the gizmos we all use everyday. Idea Lab: Impact will have a different focus. How is science and applied technology affecting real human lives? How is it impacting people and communities living on the margins of global wealth and on the margins of the technological transformations of the 21st century – whether that’s in subsaharan Africa or Appalachia or in congested great cities of the world. Basically, how is and how can science and technology change the lives of people in their every day lives – not only with their gadgets and not only for people who command great wealth, but real world impacts for everyone.
People who’ve been blogging as long as I have may remember another website with PHrMA funding which set out to tell us about the awesome innovating power of innovative innovation, the unlamented Tech Central Station. TCS dished out money to Glenn Reynolds and other bullshit merchants in the marketplace of ideas to provide cover for a whole variety of unsalubrious corporate agendas. Josh Marshall isn’t Glenn Reynolds – the sponsorship is public and I imagine that there’ll be some quality control. But still, PhRMA’s agenda on innovation involves some very, very shitty stuff indeed. There are a whole bunch of big sleazy lobby groups on Capitol Hill, but PhRMA is arguably the sleaziest.
And in that spirit, I’d like to introduce a very cool new non-sponsored section myself, “Bullshit Lab: Impact,” focused on the very cool ways in which PhRMA lobbying is affecting real human lives and impacting people and communities living on the margins of global wealth and on the margins of the technological transformations. Except maybe losing the “impacting,” since it isn’t a verb ever seen outside corporate press releases. How, for example, is PhRMA lobbying advancing the ball on shovelling insanely demanding IP requirements into international trade agreements? What are the impactful ways in which PhRMA is impacting high drug prices? What are the cutting edge techniques in which PhRMA is pushing back on patent reform for AIDS drugs in South Africa (with the lobbying help of James Glassman, whose name devoted readers may recognize from previous episodes of sponsored hackery like, well … Tech Central Station). Feel free to treat this post’s comments sections as an opportunity to provide further examples, and unleash the real world impacts of innovative lobbying innovations!!
Update – see the comments below for responses from and debate with Josh Marshall, and this follow-up post for more discussion.